MBOT News and Press, Microbot Medical Inc. From 02/28/23

HINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced that Harel Gadot, Chairman, CEO and President, Dr. Eyal Morag, Chief Medical Officer, and other le...

HINGHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), today announced that it has expanded its global presence to South America with the addition of Francisco C. Carnevale, MD, PhD, FSIR, becoming the latest key opinion leader (KOL) to join the Company’s S...

Allows Endovascular Procedure to be Performed from the Cath-Lab Control Room, Potentially Minimizing Radiation Exposure and Reducing Physical Strain for the Healthcare Providers Design Patent Complements Existing U.S. and European Design Patents as Feedback During Recent Meetings Contin...

Summary January 2023 was an amazing month to be long equities. The Russell 2000 index was up 9.8%. Before the first opening bell of 2023, I created an equal weighted and bespoke list of twenty nine stocks for my January Effect 2023 model portfolio. The January Effect 2023 portfolio ...

Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker. The Webinar is Intended for All Stakeholders Intere...

Summary On January 3, 2023, an hour before the first opening bell of 2023, I published a list of my top 29 January Effect 2023 stocks. As of the close of business, January 11, 2023, this portfolio is up a blistering +21.4% whereas the Russell 2000 is up 4.7%. Although this is a very...

Panel of Proven Medical Device Entrepreneurs and Surgical Robotics Pioneers Will Share Their Personal Experiences of Taking Innovative New Technologies from Development to Commercialization Views on the Current and Future Endovascular Market will be Highlighted Webinar will be H...

Summary In 2022, the blended total return of my two managed accounts was +5.3%. In baseball parlance, in 2022, I hit exactly 'zero' extra base hits and had to manufacture runs - meaning hitting a lot of singles, stealing bases, and hitting sacrifice flies. 2022 was one of the most d...

The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022, at 1:00pm ET Dr. Ripal Gandhi, a Renowned Miami-Based Interventional Oncologist, Will Share His Personal Experiences Having Completed Over 10...

HINGHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to strengthen its intellectual property (IP) portfolio, while advancing and securing its global commercialization strategy. It has been granted a third patent in Israel for the LIBERTY ® Robo...